Radiographic Profiling of Immune-related Adverse Events in Advanced Melanoma Patients Treated With Ipilimumab

類似資料

• Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome
  著者:: Nishino, Mizuki, 等
  出版事項: (2014)
• Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?
  著者:: Nishino, Mizuki, 等
  出版事項: (2014)
• Cancer immunotherapy and immune-related response assessment: the role of radiologists in the new arena of cancer treatment
  著者:: Nishino, Mizuki, 等
  出版事項: (2015)
• Beyond PET/CT in Hodgkin lymphoma: a comprehensive review of the role of imaging at initial presentation, during follow-up and for assessment of treatment-related complications
  著者:: Keraliya, Abhishek R., 等
  出版事項: (2015)
• Single Institution Experience of Ipilimumab 3 mg/kg with Sargramostim (GM-CSF) in Metastatic Melanoma
  著者:: Luke, Jason J., 等
  出版事項: (2015)